Perioperative camrelizumab combined with chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: A single-arm, single-center, phase II clinical trial

被引：0
|
作者：
He, J. [1 ]
Yang, Y. [1 ]
Zhou, S. [1 ]
Zhang, B. [1 ]
Han, Z. [1 ]
Wu, T. [1 ]
Qiao, Q. [1 ]
Yang, H. [1 ]
He, X. [1 ]
Wang, N. [1 ]
机构：
[1] Air Force Med Univ, Affiliate Hosp 2, Tangdu Hosp, Gen Surg Dept, Xian, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.769
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
190P
引用
收藏
页码：S1549 / S1549
页数：1
相关论文
共 50 条
  • [1] Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study
    Wu, Kunpeng
    Li, Yahua
    Li, Zongming
    Zhou, Zihe
    Ge, Xiaoyong
    Li, Yifan
    Han, Xinwei
    Chen, Peng
    Ren, Kewei
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Surufatinib plus sintilimab in patients with advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, single-center phase II trial.
    Zhang, Dong-Sheng
    Liu, Fu-Rong
    Lu, Yun-Xin
    Bai, Bing
    Zhang, Yang
    Wang, Zhi-Qiang
    Liu, Yu
    Chen, Jian-Wen
    Wang, Feng
    Xu, Rui-Hua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 358 - 358
  • [3] Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
    Wei, Jia
    Lu, Xiaofeng
    Liu, Qin
    Fu, Yao
    Liu, Song
    Zhao, Yang
    Zhou, Jiawei
    Chen, Hui
    Wang, Meng
    Li, Lin
    Yang, Ju
    Liu, Fangcen
    Zheng, Liming
    Yin, Haitao
    Yang, Yang
    Zhou, Chong
    Zeng, Ping
    Zhou, Xiaoyu
    Ding, Naiqing
    Chen, Shiqing
    Zhao, Xiaochen
    Yan, Jing
    Fan, Xiangshan
    Guan, Wenxian
    Liu, Baorui
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [4] Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
    Jia Wei
    Xiaofeng Lu
    Qin Liu
    Yao Fu
    Song Liu
    Yang Zhao
    Jiawei Zhou
    Hui Chen
    Meng Wang
    Lin Li
    Ju Yang
    Fangcen Liu
    Liming Zheng
    Haitao Yin
    Yang Yang
    Chong Zhou
    Ping Zeng
    Xiaoyu Zhou
    Naiqing Ding
    Shiqing Chen
    Xiaochen Zhao
    Jing Yan
    Xiangshan Fan
    Wenxian Guan
    Baorui Liu
    [J]. Nature Communications, 14
  • [5] Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study
    Zhong, Wen-Jin
    Lin, Jian-An
    Wu, Chu-Ying
    Wang, Jiantian
    Chen, Jun-Xing
    Zheng, Huida
    Ye, Kai
    [J]. CANCER MEDICINE, 2024, 13 (03):
  • [6] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [7] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    [J]. Journal of Translational Medicine, 21
  • [8] Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial
    Ding, Xuewei
    Li, Bin
    Xue, Qiang
    Cai, Mingzhi
    Cui, Jingli
    Wang, Baogui
    Ke, Bin
    Zhang, Rupeng
    Liang, Han
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [9] Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial
    Zhao, Yuzhou
    Li, Danyang
    Zhuang, Jing
    Li, Zhimeng
    Xia, Qingxin
    Li, Zhi
    Yu, Juan
    Wang, Jinbang
    Zhang, Yong
    Li, Ke
    Xu, Shuning
    Li, Sen
    Ma, Pengfei
    Cao, Yanghui
    Liu, Chenyu
    Xu, Chunmiao
    Liu, Zhentian
    Wei, Jinwang
    Zhang, Chengjuan
    Qiao, Lei
    Gao, Xuan
    Hou, Zhiguo
    Liu, Chenxuan
    Zheng, Rongrong
    Wang, Du
    Liu, Ying
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (05):
  • [10] Conversion therapy of concurrent chemoradiotherapy combined with tislelizumab for unresectable gastric or gastroesophageal junction adenocarcinoma: A prospective, single-arm, phase II trial
    Liu, D.
    Yang, L.
    Lu, K.
    Zhao, Q.
    Yu, J.
    Liu, Y.
    Chen, Q.
    Liu, L.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S173 - S173
12345